MedGenome and Emmes are proud to launch a strategic partnership to focus on advancing Rare Disease research.
Patients and families with rare diseases are one of the most underserved communities in medicine today. India and South Asia have the world’s largest population of people affected by rare and inherited disease.
The MedGenome – Emmes partnership will combine patients’ genomic, phenotypic and epidemiological data into custom rare disease registries.
This help bring faster and more innovative treatments to patients around the world who are suffering from rare diseases.
For more details contact:
Vice President, Corporate and Business Development at MedGenome
Phone: (416) 452-1656